Practical option context-specific guidance inside a guide
Reserve device-based options for refractory cases
- Evidence quality
- specialty guidance only, narrower than broad conservative care evidence
- Confidence
- low
- Last reviewed
- 2026-05-30
Inside the larger guide
This option belongs to What non-opioid treatments actually help chronic pain?
Read this page when you want one concrete route. Open the guide when you want the full answer, the main tradeoffs, and the reasoning across the whole decision.
Full guide What non-opioid treatments actually help chronic pain? Evidence: moderateAction-oriented guidance
What this option means
Consider peripheral nerve stimulation after standard non-opioid approaches have not worked well enough. This preserves the role of a potentially useful non-opioid option while limiting it to patients who are most likely to need escalation.
The caution is that device therapy is more specialized, more invasive, and less broadly established than medication, exercise, or rehabilitation approaches. It should be framed as a later option, not a replacement for first-line chronic pain care.
Practical takeaway
Use this as a practical default, not as a rigid rule. If the situation changes or the option stops solving the real problem, adjust rather than forcing the recommendation beyond what the evidence supports.
Evidence behind this option
The reasoning this option depends on
Evidence check
Peripheral nerve stimulation is a selected option for refractory chronic pain, not a general first-line treatment
Bottom line
Peripheral nerve stimulation may help selected patients whose chronic pain has not responded well to standard care. The ASIPP guideline supports its use as a specialized option, which makes it part of the non-opioid landscape.
What seems true
What is true is that this is a reasonable consideration in refractory cases. What is not proven is that it should be used broadly or before simpler non-opioid treatments.
What is uncertain or overstated
The practical meaning is that PNS belongs later in the pathway, after the more established medication, rehabilitation, and behavioral options have been considered.
Practical meaning
This judgment mainly rests on sources such as Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP) (guideline). Together they give the evidence base for the claim, but the confidence still depends on how direct, consistent, and decision-relevant those sources really are.
Key sources for this judgment include Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP).
Source support
Key sources behind this option
Source record
Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP)
Used to support the limited role of peripheral nerve stimulation as a selected option for refractory chronic pain. It does not prove that PNS should be used broadly or before simpler non-opioid therapies.